PepGen Inc. logo

PEPG Earnings Date: Nov 11, 2026 (Estimated) — PepGen Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $2.29
Market Cap $158.3M
P/E -1.7
52W Range $1.31 – $7.80
Next Earnings · Before open (est.)

When is PEPG's next earnings date?

PepGen Inc. (PEPG) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.27.

How did PEPG do in its last earnings report?

In its most recent report on Aug 6, 2026 (Q2 2026), PepGen Inc. posted EPS of -$0.26 versus the -$0.28 estimate, a beat of 10.3%. Revenue was $0. The stock's 1-day post-earnings move was +21.7%.

How much does PEPG stock move after earnings?

PEPG beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 19.3% (up or down) in the day after earnings.

About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-06Q2 2026-0.28-0.26+10.34%$0✅ Beat+21.72%+46.46%+60.61%
2026-05-12Q1 2026-0.31-0.26+16.13%$0✅ Beat+5.95%-17.86%-10.12%
2026-03-04Q4 2025-0.40-0.27+32.50%$0✅ Beat-18.57%-6.95%-74.41%
2025-11-12Q3 2025-0.55-0.52+5.45%$0✅ Beat+10.32%+23.44%+23.44%
2025-02-24Q4 2024-0.72-0.68+5.56%$0✅ Beat+67.15%+129.93%+24.09%
2024-11-07Q3 2024-0.87-0.66+24.14%$0✅ Beat-21.70%-36.72%-20.58%
2024-05-14Q1 2024-0.74-0.63+14.86%$0✅ Beat-1.22%-0.71%+24.95%
2024-03-06Q4 2023-1.01-0.81+19.80%$0✅ Beat-7.98%-10.77%-22.84%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .